SCYNEXIS
SCYX • NASDAQ
SCYNEXIS is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO David Gonzalez Angulo, with a market cap of $44.3M.
Market Cap$44.3M
Employees29.0
CEODavid Gonzalez Angulo
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
SCYNEXIS FAQ
Common questions about SCYNEXIS
SCYNEXIS is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $77.0K.
SCYNEXIS has approximately 29 employees.